Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Food For Special Dietary Use

Research Leaders

6 sponsors active, led by St. Boniface Hospital

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (2)

Research Network

Common Treatments

  • Food For Special Dietary Use1
  • Control Beverage1
  • Flaxseed Beverage1

Active Sponsors

  • St. Boniface Hospital1
  • Pizzey Ingredients1
  • EFKO Group1
  • Federal State Budgetary Scientific Institution1
  • Russian Science Foundation1

Top Investigators

Related Conditions

  • Emotional Regulation1
  • Cognitive Change1
  • Concentration Ability Impaired1

Activity Timeline